These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8787885

  • 21. The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
    Seyedmousavi S, Mouton JW, Melchers WJ, Brüggemann RJ, Verweij PE.
    Drug Resist Updat; 2014 Jul; 17(3):37-50. PubMed ID: 25066814
    [Abstract] [Full Text] [Related]

  • 22. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
    Stern JB, Girard P, Caliandro R.
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1065. PubMed ID: 14982812
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
    MacCallum DM, Whyte JA, Odds FC.
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE, Prince RA, Chi J, Kontoyiannis DP.
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ, Antonius T, Heijst Av, Hoogerbrugge PM, Burger DM, Warris A.
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
    Denning DW, Hall L, Jackson M, Hollis S.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis.
    Kirkpatrick WR, Perea S, Coco BJ, Patterson TF.
    J Antimicrob Chemother; 2002 Feb; 49(2):353-7. PubMed ID: 11815579
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
    Boyd NK, Zoellner CL, Swancutt MA, Bhavan KP.
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6001-2. PubMed ID: 22890768
    [Abstract] [Full Text] [Related]

  • 34. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E, Melchers WJ, Verweij PE.
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.
    Siopi M, Siafakas N, Vourli S, Zerva L, Meletiadis J.
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3973-83. PubMed ID: 25896699
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
    Chiang LY, Ejzykowicz DE, Tian ZQ, Katz L, Filler SG.
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
    Paulussen C, Boulet G, Bosschaerts T, Cos P, Fortin A, Maes L.
    Mycoses; 2015 Mar; 58(3):127-32. PubMed ID: 25590577
    [Abstract] [Full Text] [Related]

  • 40. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
    van de Sande WW, van Vianen W, ten Kate MT, Vissers J, Laurijsens J, Tavakol M, Rijnders BJ, Mathot RA, Bakker-Woudenberg IA.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.